Moreover, the combination of PD‐L1 siRNA and IL‐2 pDNA‐loaded TT‐LDCP NPs with HCC vaccine further improve the tumoricidal effect, suggesting that these immunogenic NPs could efficiently reverse immunosuppressive TME to favor antitumor immunity. The gene discussed is IL2; the disease is hepatocellular carcinoma.